Post Market Clinical Follow-up Study designed to evaluate the incidence of device- and procedure-related safety, efficacy, and efficiency (6 and 12 month outcomes) when using the AcQMap™ as an imaging and mapping system for ablation of persistent atrial fibrillation (AF).